For Immediate Release:

What Boomers Need to Know About Digestion

Enzymatic Therapy’s CompleteGest®† Renew targets aging digestive issues

GREEN BAY, WI - (October 20, 2008) Enzymatic Therapy, Inc., the manufacturer and distributor of over 200 nutritional supplements and natural medicines, has launched the answer for baby boomers wondering what happened to their digestive systems – CompleteGest^† Renew age-optimized enzymes. This breakthrough formula designed to help the boomer generation say good-bye to occasional digestive discomfort and rediscover the pleasure of eating – at any age!^†

Most boomers remember when they could eat whatever they wanted without worrying about suffering any uncomfortable side effects. There’s a biological reason they can’t enjoy foods the way they used to! According to Cheryl Myers, Vice President of Health Sciences at Enzymatic Therapy®, “As the body ages, enzyme production is dramatically reduced, so you aren’t able to break down foods as effectively as you once could. This leaves people with occasional gas and bloating after enjoying some of their favorite foods.”

CompleteGest Renew is a new, proprietary formula that goes above and beyond other digestion products on the market. It’s custom-formulated to meet the needs of people past their thirties, and designed to enhance the ability to digest problematic foods including proteins, carbohydrates, fats, wheat and dairy.^†

CompleteGest^† Renew is the newest addition to Enzymatic Therapy’s successful line of enzyme products, and is available at natural food retailers nationwide.

For nearly 30 years, Enzymatic Therapy, Inc., (ETI) based in Green Bay, Wisconsin, has been North America’s leading manufacturer and distributor of dietary supplements and natural medicines. ETI is a drug GMP audited facility and also a certified organic processor. It was the first company to introduce Ginkgo biloba, glucosamine sulfate and botanical standardization to the United States health market. The company’s products and ingredients are collectively the subject of over 2,500 independent, peer-reviewed-published clinical trials and studies. For more information, visit enzy.com.